Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.
about
Long-term course and effectiveness of combination therapy in Alzheimer diseaseBenefits of a working memory training program for inattention in daily life: a systematic review and meta-analysisAlternative medicine and Alzheimer diseaseAttainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial.The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezilUpdate on the pharmacological treatment of Alzheimer's diseaseA randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.Life extension factor klotho enhances cognition.Therapy for Alzheimer's Disease: How Effective are Current Treatments?Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study.Moving beyond the pros and cons of automating cognitive testing in pathological aging and dementia: the case for equal opportunity.Preventing loss of independence through exercise (PLIÉ): a pilot clinical trial in older adults with dementia.Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.Clinical trials in mild cognitive impairment: lessons for the future.Effects of psychotherapy for depression in children and adolescents: what we can (and can't) learn from meta-analysis and component profilingCognitive training in Alzheimer's disease: a meta-analysis of the literature.Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy.Target symptoms and outcome measures: cognition.Global assessment measures for assessing efficacy in dementia drug trials.Improving drug trials for mild to moderate Alzheimer's disease.A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive DisorderProgress update: Pharmacological treatment of Alzheimer's disease.Memantine combined with an acetyl cholinesterase inhibitor - hope for the future?Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials.Ethical issues in Alzheimer's disease: an overview.Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.Theory of mind in behavioural-variant frontotemporal dementia and Alzheimer's disease: a meta-analysis.The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial.Effect of working memory training on working memory, arithmetic and following instructions.Which Cognitive Domains are Improved by Treatment with Vortioxetine?Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study.Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's diseaseFor how long should we use symptomatic therapies to treat people with Alzheimer disease?Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.Souvenaid®: a new approach to management of early Alzheimer's disease.Reassessment of the dementia diagnosis of Alzheimer's disease in patients enrolled on the cholinesterase inhibitors dispensation program.The Case for Insurance Reimbursement of Couple Therapy.
P2860
Q24642161-18CABCC5-7858-4C38-B4C8-C34BC836EA39Q26827341-F0B0DEDD-9B73-4BBD-81E8-47BFF7628176Q28751860-759E3770-9799-42CF-891D-51344DE73A79Q30477103-E4987849-5598-47E7-89E8-091965B7EE60Q33165801-55C73E0E-D500-4760-9CD3-42E0089DDEFDQ33408028-86FBDB04-9985-4CAF-BBF3-8EB08B7D3F78Q33836947-833BE290-43D0-49C3-B1BF-AEE4C1B74D0CQ34172150-6C5A65D7-F76B-472B-9EDC-D6240C6FB5D7Q34252649-1222FEDD-16C9-4390-997E-99D2A17EE80AQ34409349-2FB2F720-0D4B-4656-A264-0D1978D49FB0Q34629649-330524E4-0DCF-4B30-8DD5-11F5BE914A98Q34630570-FA46E012-EF9A-4F08-8514-F8250C3334F8Q35074465-F5EF1D0C-7F51-413C-A9E9-26D4430C7119Q35327053-112B5D17-F472-49CF-B740-4B9C3CB92FAEQ36142255-F7E61EE2-9F6D-4569-B8E8-3B6104248002Q36293420-B2B20A73-901B-4B5A-8858-BF1FD17518F9Q36534246-B7E7409A-AA52-4BAD-AE74-7DC552AC4B44Q36632693-322454B1-3107-4983-8C61-E4DAD34329A8Q36806620-8FB1F518-5597-49C2-8BB9-FC114979793FQ36806629-0A6370A1-E7F5-4D4A-9C71-B162E2C35B68Q36806662-4BEF93FE-49F1-49AF-9DD9-AFCFC56625C3Q36821817-45441ECC-2F66-406F-BBCD-CADAB5A9E3DCQ37129735-D2C89F38-CEF6-4A4B-9B87-6F6D9EA14146Q37165577-2F28FCF0-5C3F-49E6-A4BC-F290E6ADB013Q37316293-3381C90C-2751-409F-B2FF-1FDB1E05E325Q37489106-CB8335F4-3E6F-4FA2-9AA4-9F0F849E4A43Q37899286-F0D7FBF6-FB43-4AF8-8692-5395D77309D9Q38006981-407FD5AA-3A13-46FE-AB9A-008D2620EC03Q38286246-7A6E2C43-C6B6-458D-BB9A-4B7EA30CA64FQ38321051-A4D7AD57-85EC-4EF4-BA2F-09ABCCEAB37DQ38394430-012B088E-8A42-4E1E-92F3-6B8FD57532AFQ39122493-D4EBED17-BC59-4B45-9B5A-A76460C92360Q39732375-0BDBCB9D-0C4C-4E23-A747-1E7D91281792Q42610768-7E2553F6-0AC1-44F4-9A81-149E2C8010D0Q42656131-DDC1C5AB-BE34-415A-8583-DE3F7AA411EFQ43117191-BFB9F0B2-9C6A-46E6-A99F-1192BADBE864Q43519611-59C95E98-8396-4673-B8BA-834B45FD4734Q43864462-D5534FBA-F808-4230-88D1-AE70768AF31EQ47158233-1761BFDA-BBDD-4559-9D98-5D0A4F0048DBQ47639350-4B654716-335B-4890-BD22-9CEED90A99CB
P2860
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Size of the treatment effect o ...... bition in Alzheimer's disease.
@ast
Size of the treatment effect o ...... bition in Alzheimer's disease.
@en
type
label
Size of the treatment effect o ...... bition in Alzheimer's disease.
@ast
Size of the treatment effect o ...... bition in Alzheimer's disease.
@en
prefLabel
Size of the treatment effect o ...... bition in Alzheimer's disease.
@ast
Size of the treatment effect o ...... bition in Alzheimer's disease.
@en
P2860
P356
P1476
Size of the treatment effect o ...... bition in Alzheimer's disease.
@en
P2093
Rockwood K
P2860
P304
P356
10.1136/JNNP.2003.029074
P407
P577
2004-05-01T00:00:00Z